Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Papulosquamous

Explore clinical trials studying Skin Diseases, Papulosquamous. Study availability and eligibility vary by location and protocol.

1,740 public trials 205 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Papulosquamous trial results

Completed

A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

NCT03236870

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • The First Affiliated Hospital /ID# 171398 Hefei, Anhui, China
  • Guangzhou 1st Muni People Hosp /ID# 208858 Guangzhou, Guangdong, China
  • Ruijin Hospital, Shanghai Jiaotong /ID# 169833 Shanghai, Shanghai Municipality, China
  • Traditional Chinese Medical Hospital of xinjiang uygur autonomous region /ID# 209183 Ürümqi, Xinjiang, China
View all 15 locations
View Trial Details
Completed

Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis

NCT02917434

Conditions
Arthritis, Arthritis, Psoriatic, Body Weight, +26 more
Locations
  • Department of Rheumatology at the Hospital of Alingsås Alingsås, Sweden
  • Department of Rheumatology at the Hospital of Borås Borås, Sweden
  • Department of Obesity and Internal Medicine at Sahlgrenska University Hospital Gothenburg, Sweden
  • Department of Rheumatology at Sahlgrenska University Hospital Gothenburg, Sweden
View Trial Details
Completed

Efficacy and Safety of 2 Secukinumab Regimens in 90kg or More Weight Group With Moderate/Severe Chronic Plaque Psoriasis

NCT03504852

Conditions
Body Weight, Moderate to Severe Chronic Plaque-Type Psoriasis, Pathological Conditions, Anatomical, +9 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Rogers, Arkansas, United States
  • Novartis Investigative Site Irvine, California, United States
View all 67 locations
View Trial Details
Completed

Comparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to Ustekinumab

NCT03553823

Conditions
Chronic Plaque-type Psoriasis, Pathological Conditions, Signs and Symptoms, Pruritus, +6 more
Locations
  • Novartis Investigative Site New Orleans, Louisiana, United States
  • Novartis Investigative Site East Windsor, New Jersey, United States
  • Novartis Investigative Site Philadelphia, Pennsylvania, United States
  • Novartis Investigative Site Dallas, Texas, United States
View all 14 locations
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

NCT02798211

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +13 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site El Cajon, California, United States
  • Novartis Investigative Site Fountain Valley, California, United States
View all 58 locations
View Trial Details
Completed

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

NCT03381625

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations
  • Encino Research Center Encino, California, United States
  • Apex Dermatology Denver, Colorado, United States
  • Colorado Skin Care Englewood, Colorado, United States
  • AboutSkin Dermatology & DermSurgery Greenwood Village, Colorado, United States
View Trial Details

Related conditions